文献速递妇产影像外周血管技术与安全US

不同方法筛查早发型子痫前期的比较:队列研究

Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-06-06

西班牙5个地区8个胎儿医学中心的前瞻性队列纳入10110例单胎孕妇,在孕11+0至13+6周比较三种数学模型与NICE、ACOG两种风险评分系统对早产型子痫前期的预测效能,结果显示联合母亲因素与MAP、UtA-PI、PlGF的数学模型优于风险评分系统,其中FMF模型个体水平表现最佳。

要点

  • 在固定10%筛查阳性率下,FMF模型对早产型子痫前期的检出率为72.7%(95%CI 62.9-82.6%)。
  • NICE标准在11%筛查阳性率下检出46.7%的早产型子痫前期,ACOG标准在33.8%筛查阳性率下检出65.9%。
  • FMF模型预测值与观察值的相关性最佳,AUC为0.911(95%CI 0.879-0.943)。

核心结论

  • 联合母亲因素与MAP、UtA-PI和PlGF的数学模型筛查早产型子痫前期的效能优于NICE和ACOG风险评分系统,三种算法总体预测相似但FMF模型个体水平表现最佳。

研究设计与样本

  • 西班牙5个地区8个胎儿医学中心的前瞻性队列研究,2017年9月至2019年12月纳入10110例单胎妊娠,于孕11+0至13+6周测量MAP、UtA-PI、血清PlGF和PAPP-A并转换为中位数倍数。

诊断标准与关键数值

  • 固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对早发型子痫前期的检出率分别为82.7%(95%CI 69.6-95.8%)、73.8%(95%CI 58.7-88.9%)和79.8%(95%CI 66.1-93.5%)。
  • 固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对早产型子痫前期的检出率分别为72.7%(95%CI 62.9-82.6%)、69.2%(95%CI 58.8-79.6%)和74.1%(95%CI 64.2-83.9%)。
  • 固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对全部子痫前期的检出率分别为55.1%(95%CI 48.8-61.4%)、47.1%(95%CI 40.6-53.5%)和53.9%(95%CI 47.4-60.4%)。
  • FMF模型预测值与观察值相关性最佳,AUC为0.911(95%CI 0.879-0.943),斜率为0.983(95%CI 0.846-1.120),截距为0.154(95%CI -0.091至0.397)。
  • NICE标准在11%筛查阳性率下检出46.7%(95%CI 35.3-58.0%)的早产型子痫前期,ACOG标准在33.8%筛查阳性率下检出65.9%(95%CI 55.4-76.4%)的早产型子痫前期。

临床应用与阅片要点

  • 孕11+0至13+6周筛查早产型子痫前期时,可联合母亲风险因素与MAP、UtA-PI、PlGF进行风险评估。
  • 三种数学模型对早产型子痫前期的总体预测结果相似,FMF模型在个体水平表现最佳。
  • NICE和ACOG风险评分系统的检出率低于联合MAP、UtA-PI和PlGF的数学模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the predictive performance of three different mathematical models for first-trimester screening of pre-eclampsia (PE), which combine maternal risk factors with mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI) and serum placental growth factor (PlGF), and two risk-scoring systems.

METHODS: This was a prospective cohort study performed in eight fetal medicine units in five different regions of Spain between September 2017 and December 2019. All pregnant women with singleton pregnancy and a non-malformed live fetus attending their routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation were invited to participate in the study. Maternal characteristics and medical history were recorded and measurements of MAP, UtA-PI, serum PlGF and pregnancy-associated plasma protein-A (PAPP-A) were converted into multiples of the median (MoM). Risks for term PE, preterm PE (< 37 weeks' gestation) and early PE (< 34 weeks' gestation) were calculated according to the FMF competing-risks model, the Crovetto et al. logistic regression model and the Serra et al. Gaussian model. PE classification was also performed based on the recommendations of the National Institute for Health and Care Excellence (NICE) and the American College of Obstetricians and Gynecologists (ACOG). We estimated detection rates (DR) with their 95% CIs at a fixed 10% screen-positive rate (SPR), as well as the area under the receiver-operating-characteristics curve (AUC) for preterm PE, early PE and all PE for the three mathematical models. For the scoring systems, we calculated DR and SPR. Risk calibration was also assessed.

RESULTS: The study population comprised 10 110 singleton pregnancies, including 32 (0.3%) that developed early PE, 72 (0.7%) that developed preterm PE and 230 (2.3%) with any PE. At a fixed 10% SPR, the FMF, Crovetto et al. and Serra et al. models detected 82.7% (95% CI, 69.6-95.8%), 73.8% (95% CI, 58.7-88.9%) and 79.8% (95% CI, 66.1-93.5%) of early PE; 72.7% (95% CI, 62.9-82.6%), 69.2% (95% CI, 58.8-79.6%) and 74.1% (95% CI, 64.2-83.9%) of preterm PE; and 55.1% (95% CI, 48.8-61.4%), 47.1% (95% CI, 40.6-53.5%) and 53.9% (95% CI, 47.4-60.4%) of all PE, respectively. The best correlation between predicted and observed cases was achieved by the FMF model, with an AUC of 0.911 (95% CI, 0.879-0.943), a slope of 0.983 (95% CI, 0.846-1.120) and an intercept of 0.154 (95% CI, -0.091 to 0.397). The NICE criteria identified 46.7% (95% CI, 35.3-58.0%) of preterm PE at 11% SPR and ACOG criteria identified 65.9% (95% CI, 55.4-76.4%) of preterm PE at 33.8% SPR.

CONCLUSIONS: The best performance of screening for preterm PE is achieved by mathematical models that combine maternal factors with MAP, UtA-PI and PlGF, as compared to risk-scoring systems such as those of NICE and ACOG. While all three algorithms show similar results in terms of overall prediction, the FMF model showed the best performance at an individual level. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cuenca-Gómez D, De Paco Matallana C, Rolle V, et al. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study. Ultrasound Obstet Gynecol. 2024. PMID: 38411276. doi:10.1002/uog.27622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。